新型冠状病毒肺炎(COVID-19)经方防治推荐方案(国际第1版)

2020-06-30 中医相关专家组(统称) 江苏中医药.2020.52(6):1-7.

经方较早介入了中国对COVID-19的防治。2020年1月21日政府部门便派出中医专家到武汉研讨COVID-19的草药治疗方案。2020年1月22日中国国家卫生健康委员会在诊疗方案中对COVID-19

中文标题:

新型冠状病毒肺炎(COVID-19)经方防治推荐方案(国际第1版)

发布日期:

2020-06-30

简要介绍:

经方较早介入了中国对COVID-19的防治。2020年1月21日政府部门便派出中医专家到武汉研讨COVID-19的草药治疗方案。2020年1月22日中国国家卫生健康委员会在诊疗方案中对COVID-19的草药治疗(主要是经方)提出了规范化方案。2020年3月31日中国公布了中医治疗各类型COVID-19的临床研究结果,初步肯定了经方的疗效。

为了进一步发挥经方防治COVID-19的作用,我们在调查古代文献的基础上,结合当今临床研究成果,从群体性治疗方、个体化治疗方、心理干预方、预防方等四个层面提供了经方干预方案,以供专业人士参考。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=新型冠状病毒肺炎_COVID_1_省略__经方防治推荐方案_国际第1版_黄煌.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ec7161c00193254f, title=新型冠状病毒肺炎(COVID-19)经方防治推荐方案(国际第1版), enTitle=, guiderFrom=江苏中医药.2020.52(6):1-7., authorId=0, author=, summary=经方较早介入了中国对COVID-19的防治。2020年1月21日政府部门便派出中医专家到武汉研讨COVID-19的草药治疗方案。2020年1月22日中国国家卫生健康委员会在诊疗方案中对COVID-19, cover=https://img.medsci.cn/202079/1594233072458_2020535.jpg, journalId=0, articlesId=null, associationId=1108, associationName=中医相关专家组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Tue Jun 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p style="color: #373737;">经方较早介入了中国对COVID-19的防治。2020年1月21日政府部门便派出中医专家到武汉研讨COVID-19的草药治疗方案。2020年1月22日中国国家卫生健康委员会在诊疗方案中对COVID-19的草药治疗(主要是经方)提出了规范化方案。2020年3月31日中国公布了中医治疗各类型COVID-19的临床研究结果,初步肯定了经方的疗效。</p> <div class="one_info2"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>为了进一步发挥经方防治COVID-19的作用,我们在调查古代文献的基础上,结合当今临床研究成果,从群体性治疗方、个体化治疗方、心理干预方、预防方等四个层面提供了经方干预方案,以供专业人士参考。</p> </div> </div> </div> <div class="box_info">&nbsp;</div>, tagList=[TagDto(tagId=104903, tagName=经方)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=67279, guiderKeyword=“经方”, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4153, appHits=103, showAppHits=0, pcHits=826, showPcHits=4050, likes=3, shares=9, comments=4, approvalStatus=1, publishedTime=Thu Jul 09 02:32:03 CST 2020, publishedTimeString=2020-06-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 09 02:31:32 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 16:15:59 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=新型冠状病毒肺炎_COVID_1_省略__经方防治推荐方案_国际第1版_黄煌.pdf)])
新型冠状病毒肺炎_COVID_1_省略__经方防治推荐方案_国际第1版_黄煌.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1003068, encodeId=956e10030680f, content=很有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210803/18a80d2367814f61bbe4c923e65f1d98/16479f926d194fa8a9ea5e1f2e022e9b.jpg, createdBy=e1981971406, createdName=1e1606abm78(暂无匿称), createdTime=Tue Jul 27 18:03:37 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811102, encodeId=dbe381110208, content=怎么才能获得积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65585391265, createdName=ms4000000219426640, createdTime=Wed Aug 19 16:44:40 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801810, encodeId=076d8018101e, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>中医遗憾的是没有強的医学证据,因此国际认可度差, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Jul 09 07:31:57 CST 2020, time=2020-07-09, status=1, ipAttribution=)]
    2021-07-27 1e1606abm78(暂无匿称)

    很有指导意义

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1003068, encodeId=956e10030680f, content=很有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210803/18a80d2367814f61bbe4c923e65f1d98/16479f926d194fa8a9ea5e1f2e022e9b.jpg, createdBy=e1981971406, createdName=1e1606abm78(暂无匿称), createdTime=Tue Jul 27 18:03:37 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811102, encodeId=dbe381110208, content=怎么才能获得积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65585391265, createdName=ms4000000219426640, createdTime=Wed Aug 19 16:44:40 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801810, encodeId=076d8018101e, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>中医遗憾的是没有強的医学证据,因此国际认可度差, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Jul 09 07:31:57 CST 2020, time=2020-07-09, status=1, ipAttribution=)]
    2020-08-19 ms4000000219426640

    怎么才能获得积分

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1003068, encodeId=956e10030680f, content=很有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210803/18a80d2367814f61bbe4c923e65f1d98/16479f926d194fa8a9ea5e1f2e022e9b.jpg, createdBy=e1981971406, createdName=1e1606abm78(暂无匿称), createdTime=Tue Jul 27 18:03:37 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811102, encodeId=dbe381110208, content=怎么才能获得积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65585391265, createdName=ms4000000219426640, createdTime=Wed Aug 19 16:44:40 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801810, encodeId=076d8018101e, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>中医遗憾的是没有強的医学证据,因此国际认可度差, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Thu Jul 09 07:31:57 CST 2020, time=2020-07-09, status=1, ipAttribution=)]
    2020-07-09 lovetcm

    #新冠肺炎#中医遗憾的是没有強的医学证据,因此国际认可度差

    0